Postgraduation Program in Medical Sciences, Universidade Federal Fluminense, Niterói, Rio de Janeiro, Brazil.
Fresenius Medical Care Brazil, Rio de Janeiro, Brazil.
BMC Nephrol. 2022 Feb 23;23(1):77. doi: 10.1186/s12882-022-02705-x.
Although Brazil has one of the largest populations on haemodialysis (HD) in the world, data regarding patients' characteristics and the variables associated with risk of death are scanty.
This is a retrospective analysis of all adult patients who initiated on maintenance HD at 23 dialysis centres in Brazil between 2012 and 2017. Patients were censored after 60 months of follow-up or at the end of 2019.
A total of 5,081 patients were included in the analysis. The median age was 59 years, 59.4% were men, 37.5% had diabetes as the cause of kidney failure. Almost 70% had a central venous catheter (CVC) as the initial vascular access, about 60% started dialysis in the hospital, and fluid overload (FO) by bioimpedance assessment was seen in 45% of patients. The 60-month survival rate was 51.4%. In the Cox regression analysis, being older (P<0.0001), starting dialysis in the hospital (P=0.016), having diabetes as the cause of kidney failure (P=0.001), high alkaline phosphatase (P=0.005), CVC as first vascular access (P=0.023), and FO (P<0.0001) were associated with higher death risk, whereas higher body mass index (P=0.015), haemoglobin (P=0.004), transferrin saturation (P=0.002), and serum albumin (P<0.0001) were associated with better survival. The same variables, except initial CVC use (P=0.14), were associated with death risk in an analysis of subdistribution proportional hazards ratio including the competing outcomes.
The present study gives an overview of a large HD population in a developing country and identifies the main predictors of mortality, including some potentially modifiable ones, such as unplanned initiation of dialysis in the hospital and fluid overload.
巴西是世界上接受血液透析(HD)治疗的人口最多的国家之一,但有关患者特征和与死亡风险相关的变量的数据却很少。
这是对 2012 年至 2017 年间巴西 23 个透析中心接受维持性 HD 治疗的所有成年患者进行的回顾性分析。患者在随访 60 个月或 2019 年底后被删失。
共纳入 5081 例患者。中位年龄为 59 岁,59.4%为男性,37.5%的患者肾衰竭病因是糖尿病。近 70%的患者初始血管通路为中心静脉导管(CVC),约 60%的患者在医院开始透析,45%的患者存在生物阻抗评估的液体超负荷(FO)。60 个月的生存率为 51.4%。在 Cox 回归分析中,年龄较大(P<0.0001)、在医院开始透析(P=0.016)、肾衰竭病因是糖尿病(P=0.001)、碱性磷酸酶较高(P=0.005)、CVC 作为初始血管通路(P=0.023)和 FO(P<0.0001)与较高的死亡风险相关,而较高的体重指数(P=0.015)、血红蛋白(P=0.004)、转铁蛋白饱和度(P=0.002)和血清白蛋白(P<0.0001)与更好的生存相关。在包括竞争结局的亚分布比例风险比分析中,除初始 CVC 使用(P=0.14)外,上述变量与死亡风险相关。
本研究概述了发展中国家一个大型 HD 人群,并确定了死亡率的主要预测因素,包括一些潜在可改变的因素,如医院计划外开始透析和液体超负荷。